trial

Efficacy of Equine Assisted Therapy on Negative Symptoms in Patients With Schizophrenia

NCTId NCT03935243
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 16 (estimated)
Sponsored by University of Zurich
Primary completion 2020-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
16 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
None
Start
2019-09-10
Primary completion
2020-05
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
equine assisted therapy

Sponsors

University of ZurichLead Sponsor

Investigators

1
Nathalie Brackmann, Dr. phil.Principal Investigator

Sites

1 total
Zurich, Switzerland

Facts & assertions

4 sourced
Enrollment
16
Phase
NA
Primary Completion Date
2020-05
Status
UNKNOWN
relationships
The graph out of here
drug
equine assisted therapy
drug
lead_sponsor
University of Zurich
company
indication
Animal Assisted Therapy
indication
investigator
Nathalie Brackmann, Dr. phil.
person